Medication-Assisted Therapy for Treatment of Pediatric OCD

Study Detail

Research to Help Children with Refractory OCD

Do you have a child between the ages of 7 and 17 with OCD or symptoms of OCD? Is your child free of medication or on a stable dose of medication with no planned changes? Has your child failed to improve with previous therapy? If so, your child may be eligible for a research study available through the UCLA Childhood OCD, Anxiety and Tic Disorders Program!

Through a research grant from the International OCD Foundation, we are conducting research comparing whether an existing medication (memantine) improves the benefits of Cognitive-Behavioral Therapy (CBT) relative to a placebo pill.

Participation involves:

  • Initial visit to UCLA to assess eligibility and OCD severity
  • A one-time blood draw
  • MRI brain scans (before and after)
  • 8 weeks of concurrent CBT through the UCLA Pediatric OCD, Anxiety and Tic Disorders Clinic
  • 3-month and 6-month follow ups
  • Payment of up to $100

Please contact 310-794-9201 or email for more

Review and Approval

IRB Flyer: application/pdf iconMemantine MRS Flyer.pdf

Renewal Date: 2017, May 10